Despite our discovery of rs28609134 as an eQTL downregulating SRD5A3, this function in tissues apart from the tumor site also suggests a potential impact on systemic androgen metabolism, which may contribute to an altered hormonal environment and influence disease progression beyond the primary tumor microenvironment. This evidence concerns the gene SRD5A3 and neoplasm.